Home/Filings/4/0001628280-21-018433
4//SEC Filing

Levine James E. 4

Accession 0001628280-21-018433

CIK 0001213037other

Filed

Sep 12, 8:00 PM ET

Accepted

Sep 13, 8:12 AM ET

Size

10.1 KB

Accession

0001628280-21-018433

Insider Transaction Report

Form 4
Period: 2021-09-10
Levine James E.
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2021-09-10$6.62/sh+5,000$33,1005,000 total
  • Purchase

    Common Stock

    2021-09-10$6.75/sh+5,000$33,75010,000 total
  • Purchase

    Common Stock

    2021-09-10$6.38/sh+10,000$63,80020,000 total
  • Purchase

    Common Stock

    2021-09-10$6.35/sh+5,000$31,75025,000 total
  • Purchase

    Common Stock

    2021-09-10$6.32/sh+5,000$31,60030,000 total

Issuer

Cardiff Oncology, Inc.

CIK 0001213037

Entity typeother

Related Parties

1
  • filerCIK 0001463151

Filing Metadata

Form type
4
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 8:12 AM ET
Size
10.1 KB